MGLN On Other Exchanges

magellan health inc (MGLN) Snapshot

Previous Close
Day High
Day Low
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for MAGELLAN HEALTH INC (MGLN)

magellan health inc (MGLN) Related Bloomberg News

View More Bloomberg News

magellan health inc (MGLN) Related Businessweek News

No Related Businessweek News Found

magellan health inc (MGLN) Details

Magellan Health, Inc. provides healthcare management services in the United States. The company operates in Healthcare and Pharmacy Management segments. The Healthcare segment offers carve-out management services for behavioral health; employee assistance plans (EAP); and other areas of specialty healthcare, including diagnostic imaging, musculoskeletal management, cardiac, and physical medicine. It also contracts with state Medicaid agencies, and the centers for Medicare and Medicaid services to manage care for beneficiaries under Medicaid and Medicare programs, such as healthcare and long-term support services through its network of medical and behavioral health professionals, clinics, hospitals, nursing facilities, home care agencies, and ancillary service providers. The Pharmacy Management segment comprises products and solutions that provide clinical and financial management of pharmaceuticals paid under medical and pharmacy benefit programs. It offers pharmacy benefit management services, such as pharmaceutical dispensing services; pharmacy benefit administration for state Medicaid and other government sponsored programs; clinical and formulary management programs; medical pharmacy management programs; and programs for the integrated management of specialty drugs that treat complex conditions. The company provides services to health plans and other managed care organizations, employers, labor unions, various military and governmental agencies, and third party administrators. Magellan Health, Inc. was founded in 1969 and is headquartered in Scottsdale, Arizona.

10,500 Employees
Last Reported Date: 02/28/19
Founded in 1969

magellan health inc (MGLN) Top Compensated Officers

Chairman, CEO & CEO of Magellan Healthcare
Total Annual Compensation: $1.4M
Chief Financial Officer
Total Annual Compensation: $706.5K
Chief Executive Officer of Magellan Rx Manage...
Total Annual Compensation: $540.0K
General Counsel & Secretary
Total Annual Compensation: $595.9K
Chief Human Resources Officer
Total Annual Compensation: $490.2K
Compensation as of Fiscal Year 2018.
magellan health inc
Magellan Health, Inc. Provides Earnings Guidance for 2019

Magellan Health, Inc. announced that it provided earnings guidance for 2019. For the period, the company expects net revenue to be $7,000 million to $7,200 million. Net income to be $52.0 million to $79.0 million. Earnings per share to be $2.14 to $3.25.

Magellan Health, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2019

Magellan Health, Inc. announced earnings results for the first quarter ended March 31, 2019. For the first quarter, the company announced total revenue was USD 1,739.489 million compared to USD 1,805.077 million a year ago. Net income was USD 431,000 compared to USD 11.452 million a year ago. Basic earnings per share was USD 0.02 compared to USD 0.47 a year ago. Diluted earnings per share was USD 0.02 compared to USD 0.45 a year ago.

Magellan Health, Inc. Announces the Retirement of Board of Directors

On April 22, 2019, Matthew Simas and Eran Broshy notified Magellan Health, Inc. that they will retire from the company’s board of directors effective at the company’s upcoming 2019 Annual Meeting of Shareholders and therefore will not stand for re-election. Additionally, on April 22, 2019, John Agwunobi, whose term expires in 2020, notified the Company that he will retire from board of directors effective at the 2019 Annual Meeting and therefore he will resign effective as of that time. The decision by Messrs. Simas, Broshy and Agwunobi not to stand for re-election or to resign, as the case may be, was not because of a disagreement with the Company on any matter relating to the Company’s operations, policies or practices.


The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

MGLN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for MGLN.
View Industry Companies

Industry Analysis


Industry Average

Valuation MGLN Industry Range
Price/Earnings 100.0x
Price/Sales 0.2x
Price/Book 1.3x
Price/Cash Flow 11.1x
TEV/Sales 0.1x

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact MAGELLAN HEALTH INC, please visit Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at